88 FR 91 pg. 30277 - Foreign-Trade Zone (FTZ) 76; Authorization of Production Activity; MannKind Corporation; (Pharmaceuticals: Treprostinil); Danbury, Connecticut
Type: NOTICEVolume: 88Number: 91Page: 30277
Page: 30277Docket number: [B-2-2023]
FR document: [FR Doc. 2023-10056 Filed 5-10-23; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-2-2023]
Foreign-Trade Zone (FTZ) 76; Authorization of Production Activity; MannKind Corporation; (Pharmaceuticals: Treprostinil); Danbury, Connecticut
On January 6, 2023, MannKind Corporation submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 76B, in Danbury, Connecticut.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (88 FR 2323, January 13, 2023). On May 8, 2023, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: May 8, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-10056 Filed 5-10-23; 8:45 am]
BILLING CODE 3510-DS-P